Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 73
- −3 vs. Q2 2022
- Portfolio value
- $1.78B
- +$199.2M (+12.6%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $139.7M | 7.9% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $101.7M | 5.7% | 00.0% | Unchanged | History |
| RXDXPrometheus Biosciences, Inc. | COM | 1,714,000 | $101.1M | 5.7% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $97.6M | 5.5% | +1,345,636+64.8% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,303,700 | $89.0M | 5.0% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,984,264 | $78.6M | 4.4% | +500,000+14.4% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $67.4M | 3.8% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $58.7M | 3.3% | −116,000−5.3% | Reduced | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $56.7M | 3.2% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,169,132 | $48.5M | 2.7% | −500,000−18.7% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $42.8M | 2.4% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,571,928 | $42.8M | 2.4% | +1,109,570+45.1% | Added | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,154,058 | $41.0M | 2.3% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $38.1M | 2.1% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $37.6M | 2.1% | −334,841−9.6% | Reduced | History |
| RCUSArcus Biosciences, Inc. | COM | 1,432,200 | $37.5M | 2.1% | 00.0% | Unchanged | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $33.8M | 1.9% | 00.0% | Unchanged | – |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $33.2M | 1.9% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $32.9M | 1.8% | 00.0% | Unchanged | History |
| RETAReata Pharmaceuticals Inc | CL A | 1,239,000 | $31.1M | 1.8% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $29.7M | 1.7% | +850,000 | New | History |
| VERUVeru Inc. | COM | 2,500,000 | $28.8M | 1.6% | +2,500,000 | New | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $28.3M | 1.6% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 6,871,642 | $24.9M | 1.4% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $24.3M | 1.4% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $23.8M | 1.3% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $23.5M | 1.3% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $23.4M | 1.3% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 200,000 | $22.1M | 1.2% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $21.7M | 1.2% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 1,263,930 | $20.7M | 1.2% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 1,250,000 | $19.6M | 1.1% | +1,250,000 | New | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $19.3M | 1.1% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,935,133 | $18.5M | 1.0% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $18.3M | 1.0% | 00.0% | Unchanged | – |
| KNTEKinnate Biopharma Inc. | COM | 1,522,559 | $18.2M | 1.0% | −325,000−17.6% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $18.2M | 1.0% | 00.0% | Unchanged | History |
| BPMCBlueprint Medicines Corp | COM | 275,000 | $18.1M | 1.0% | −232,374−45.8% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $16.0M | 0.9% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $13.8M | 0.8% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 570,417 | $10.8M | 0.6% | +570,417 | New | History |
| ETNB89bio, Inc. | COM | 1,400,000 | $8.11M | 0.5% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 350,000 | $7.84M | 0.4% | −150,000−30.0% | Reduced | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 70,000 | $7.23M | 0.4% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $6.69M | 0.4% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $6.54M | 0.4% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 698,861 | $6.42M | 0.4% | −1,540,000−68.8% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 500,000 | $6.38M | 0.4% | +500,000 | New | History |
| COGTCogent Biosciences, Inc. | COM | 425,000 | $6.34M | 0.4% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 1,175,000 | $5.73M | 0.3% | 00.0% | Unchanged | – |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $5.39M | 0.3% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $5.29M | 0.3% | 00.0% | Unchanged | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 892,057 | $5.17M | 0.3% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $5.03M | 0.3% | 00.0% | Unchanged | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $5.01M | 0.3% | 00.0% | Unchanged | – |
| EQRXEQRx, Inc. | COM | 1,000,000 | $4.95M | 0.3% | 00.0% | Unchanged | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $4.90M | 0.3% | 00.0% | Unchanged | – |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $3.96M | 0.2% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 2,134,598 | $3.78M | 0.2% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $3.46M | 0.2% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $3.40M | 0.2% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,054,000 | $3.37M | 0.2% | 00.0% | Unchanged | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,500,000 | $2.58M | 0.1% | +1,500,000 | New | History |
| IRONDisc Medicine, Inc. | COM | 1,300,000 | $2.13M | 0.1% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $1.99M | 0.1% | 00.0% | Unchanged | – |
| MREOMereo BioPharma Group plc | SPON ADS | 2,250,000 | $1.94M | 0.1% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $1.13M | 0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $619.0K | <0.1% | 00.0% | Unchanged | History |
| CDAKCodiak BioSciences, Inc. | COM | 488,157 | $382.0K | <0.1% | −361,908−42.6% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $351.0K | <0.1% | 00.0% | Unchanged | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 56,950 | $68.0K | <0.1% | 00.0% | Unchanged | – |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $45.0K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $11.0K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q2 2022 (9)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| TPTXTurning Point Therapeutics, Inc. | COM | 570,745 | $42.9M | 2.7% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 500,000 | $37.1M | 2.4% | – |
| BMEABiomea Fusion, Inc. | COM | 1,188,405 | $14.2M | 0.9% | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,341,009 | $14.1M | 0.9% | History |
| GHRSGH Research PLC | ORDINARY SHARES | 1,013,399 | $10.1M | 0.6% | History |
| SLDBSolid Biosciences Inc. | COM | 5,336,031 | $3.29M | 0.2% | History |
| EPIXESSA Pharma Inc. | COM NEW | 724,500 | $2.28M | 0.1% | History |
| ALGSAligos Therapeutics, Inc. | COM | 1,526,048 | $1.85M | 0.1% | History |
| ELEVElevation Acquisition Group Inc. | COM | 872,780 | $1.22M | 0.1% | History |